During an inspection on February 12, 2024, the Food and Drug Administration (FDA) issued five citations to Yamasa Enterprises, Inc., located in Los Angeles, for violations concerning foodborne biological hazards, according to data posted on the FDA’s website.
The FDA website indicates that the citations were delivered to the company as follows:
- ‘You did not implement the verification procedures listed in your HACCP plan.’
- ‘Your HACCP plan does not list the food safety hazards that are reasonably likely to occur.’
- ‘You did not take corrective action that ensured affected product was not entered into commerce and the cause of the deviation was corrected.’
- ‘You did not review some of your critical control point monitoring records within one week after the records were made.’
- ‘Your sanitation control records do not accurately document the conditions or practices observed at your firm.’
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
